Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 215,473,737 papers from all fields of science
Search
Sign In
Create Free Account
antineoplastons
Known as:
Antineoplaston Agent
, antineoplaston
A peptide, amino acid derivative, and/or organic acid extracted from blood serum, urine, or synthesized chemically, that inhibits the methylation of…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma
R. Blaskiewicz
Child's Nervous System
2014
Corpus ID: 9267375
Although Burzynski et al. conclude that antineoplastons are a useful treatment, their results do not adequately support their…
Expand
2005
2005
Long-term Survival of High-Risk Pediatric Patients With Primitive Neuroectodermal Tumors Treated With Antineoplastons A10 and AS2-1
S. Burzynski
,
R. Weaver
,
+4 authors
V. Dolgopolov
Integrative Cancer Therapies
2005
Corpus ID: 38166285
Primitive neuroectodermal tumors (PNETs) are usually successfully treated with craniospinal radiation and chemotherapy; however…
Expand
2005
2005
Attitudes of patients to alternative medicine for cancer treatment.
A. Chartterjee
,
Subir Ganguly
,
S. Pal
,
A. Chatterjee
,
G. Mukhopadhyay
,
Rs Bhakta
Asian Pacific Journal of Cancer Prevention
2005
Corpus ID: 6848115
Awareness of attitudes to different types of medicine is very important for estabishment of cancer prevention programs…
Expand
Review
2004
Review
2004
The Present State of Antineoplaston Research (1)
S. Burzynski
Integrative Cancer Therapies
2004
Corpus ID: 9522797
Antineoplastons work as molecular switches, which regulate expression of genes p53 and p21 through demethylation of promoter…
Expand
2003
2003
Gene silencing--a new theory of aging.
S. Burzynski
Medical Hypotheses
2003
Corpus ID: 27159261
1999
1999
Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
Jan C. Buckner
,
Mark G. Malkin
,
+6 authors
William D. Figg
Mayo Clinic proceedings
1999
Corpus ID: 12205429
OBJECTIVE To assess the pharmacokinetics, toxicity, and efficacy of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261…
Expand
1996
1996
Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma.
H. Tsuda
,
A. Iemura
,
M. Sata
,
M. Uchida
,
K. Yamana
,
H. Hara
The Kurume Medical Journal
1996
Corpus ID: 23666211
Antineoplastons, first described by Burzynski, are naturally occurring peptides and amino acid derivatives which control…
Expand
1987
1987
Phase I clinical studies of antineoplaston A5 injections.
S. Burzynski
,
E. Kubove
,
B. Burzynski
Drugs under experimental and clinical research
1987
Corpus ID: 39322779
Antineoplaston A5 is a mixture of small peptides and amino acid derivatives isolated from human urine which show a unique pattern…
Expand
1987
1987
Stereochemical modelling studies of the interaction of antineoplaston A10 with DNA.
L. Hendry
,
T. G. Muldoon
,
S. Burzynski
,
J. Copland
,
A. Lehner
Drugs under experimental and clinical research
1987
Corpus ID: 37506853
Antineoplaston A10 (3-phenylacetylamino-2,6-piperidinedione), a peptide analogue originally isolated from human urine, has been…
Expand
Review
1986
Review
1986
Antineoplastons: history of the research (I).
S. Burzynski
Drugs under experimental and clinical research
1986
Corpus ID: 10404923
Antineoplastons are naturally-occurring peptides and amino acid derivatives which control neoplastic growth. The theory of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE